Insider Transactions Reported by 17 Insiders of AMICUS THERAPEUTICS, INC.

Symbol
FOLD on Nasdaq
Location
Princeton, NJ

Insiders trading volume in the past year

AMICUS THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradley L. Campbell President and CEO, Director $14,612,166 -$2,215,727 -13% 20 Jan 2026
John F. Crowley Executive Chairman, Director $8,521,769 01 Mar 2024
Ellen Rosenberg Chief Legal Officer $6,843,457 -$958,478 -12% 02 Jan 2026
Jeff Castelli Chief Development Officer $5,840,867 -$773,659 -12% 02 Jan 2026
Daphne Quimi Chief Financial Officer $4,926,692 17 Jan 2023
David Michael Clark Chief People Officer $3,165,242 -$1,148,246 -27% 02 Jan 2026
Simon N.R. Harford Chief Financial Officer $2,046,228 26 Dec 2025
Samantha Prout Chief Accounting Officer $1,797,320 02 Jan 2026
BURKE W. WHITMAN Director $736,493 05 Jun 2025
MICHAEL RAAB Director $719,471 05 Jun 2025
GLENN SBLENDORIO Director $719,471 05 Jun 2025
Lynn Dorsey Bleil Director $707,573 05 Jun 2025
MARGARET G. MCGLYNN Director $568,525 05 Jun 2025
CRAIG A. WHEELER Director $525,558 05 Jun 2025
EIRY ROBERTS Director $473,667 05 Jun 2025
Michael Aaron Kelly Director $450,026 05 Jun 2025
ROBERT ESSNER Director $384,647 10 Jun 2021

Recent Insider Transactions by Companies or Individuals for AMICUS THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.